High-level aminoglycoside resistance in the beta-hemolytic group G Streptococcus isolate BM2721

Area of Science:

• Microbiology
• Genetics
• Molecular Biology

Background:

• Beta-hemolytic group G Streptococcus are significant human pathogens.
• Aminoglycoside antibiotics are crucial for treating bacterial infections.
• Emergence of antibiotic resistance in Streptococcus poses a therapeutic challenge.

Purpose of the Study:

• To investigate the molecular mechanisms underlying high-level aminoglycoside resistance in a clinical isolate of group G Streptococcus.
• To identify the specific aminoglycoside-modifying enzymes responsible for resistance.
• To determine the genetic context and origin of the resistance genes.

Main Methods:

• Phenotypic characterization of antibiotic resistance in Streptococcus BM2721.
• Identification and sequencing of genes encoding aminoglycoside-modifying enzymes.
• Analysis of transposon structures and their potential role in gene acquisition.
• Comparative genomic analysis to trace the origin of transposons.

Main Results:

• The clinical isolate BM2721 demonstrated high-level resistance to multiple aminoglycosides.
• Three aminoglycoside-modifying enzyme genes, AAC(6 extprime)-APH(2 extprime extprime), APH(3 extprime)-III, and ANT(6), were identified.
• These resistance genes were found to be located adjacently.
• Evidence suggests a recombination event between staphylococcal transposons Tn4001 and Tn5405 facilitated the gene cluster formation.

Conclusions:

• The study elucidates a novel genetic mechanism for aminoglycoside resistance in group G Streptococcus.
• The findings highlight the role of horizontal gene transfer and transposon-mediated recombination in the dissemination of antibiotic resistance.
• Understanding these mechanisms is critical for developing strategies to combat antibiotic resistance in clinical settings.